Is Testosterone Replacement Safe in Men with Cardiovascular Disease?

Area of Science:

• Endocrinology
• Men's Health
• Cardiovascular Science

Background:

• Testosterone is a key anabolic hormone influencing male sexual development, muscle mass, and bone density.
• Male hypogonadism diagnosis and testosterone replacement therapy (TRT) prescriptions have increased, particularly in elderly men.
• The link between testosterone levels and cardiovascular outcomes is complex and yields conflicting research findings.

Purpose of the Study:

• To summarize the role of testosterone and the considerations for testosterone replacement therapy (TRT).
• To highlight the increasing diagnosis and treatment of male hypogonadism.
• To discuss the challenges and risks associated with TRT, particularly in relation to cardiovascular health.

Main Methods:

• Review of existing literature on testosterone function, hypogonadism, and TRT.
• Analysis of trends in male hypogonadism diagnosis and TRT prescriptions.
• Examination of studies investigating the relationship between testosterone and cardiovascular outcomes.

Main Results:

• Testosterone is crucial for primary and secondary sexual characteristics, muscle mass, and bone density.
• TRT aims to alleviate symptoms of low testosterone by restoring levels to mid-normal ranges.
• The cardiovascular safety of TRT remains debated, necessitating risk-benefit assessment in patients with cardiovascular disease or risk factors.

Conclusions:

• Symptomatic hypogonadal men may benefit from TRT after confirmed diagnosis.
• Careful patient selection and risk-benefit discussions are essential before initiating or continuing TRT.
• Further research is needed to clarify the long-term cardiovascular implications of TRT.